https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/clinical-case-and-interactive-session-6 https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/clinical-case-and-interactive-session-5 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/critically-ill-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/critically-ill-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/peri-operative-management-of-liver-transplant-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/acute-on-chronic-liver-failure-in-cirrhosis https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/when-cancer-immunotherapy-strikes-the-nervous-system-managing-iraes-in-neurology https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/clinical-case-and-interactive-session-4 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/4f-pcc-setting-the-new-standard-for-restoring-thrombin-generation https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/ai-meets-clinical-practice-the-future-of-diagnosis-and-patient-care https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/bacterial-infections https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/when-and-how-to-reverse-anticoagulants https://sciencehub.octapharma.com/resources-sea/spcs-sea https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/clinical-case-and-interactive-session-3b https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/the-fibrinogen-concentrate-vs-cryoprecipitate-decision https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-fibryga-my https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/generalized-myasthenia-gravis-in-the-era-of-targeted-therapies-where-do-we-stand https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25 https://sciencehub.octapharma.com/content-library https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/clinical-case-and-interactive-session-3a https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/evolving-evidence-for-factor-concentrates-in-surgical-bleeding https://sciencehub.octapharma.com/e-learnings https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/children-with-mogad-nmosd-and-ms-navigating-among-abbreviations https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/ecmo-between-bleeding-thrombosis https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/factor-concentrates-in-real-practice https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/2025 https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/zastosowanie-koncentratu-fibrynogenu-w-hematoonkologii https://sciencehub.octapharma.com/resources-spain https://sciencehub.octapharma.com/resources-sea/newsletter https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/autoimmune-encephalitis-from-psychiatric-mimics-to-life-saving-immunotherapy https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/anticoagulation-and-thrombosis-prophylaxis-in-the-critical-ill-patient https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/reversing-fxa-inh-timing-tools-and-evidence https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/krwotok-okoloporodowy https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/pathogenesis-and-therapeutic-landscape-of-multifocal-motor-neuropathy https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/inflammation-coagulation https://sciencehub.octapharma.com/resources-russia/lectures/bm/2025/the-superior-effect-of-concentrates-in-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/long-term-albumin-treatment-of-ascites https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/the-superior-effect-of-concentrates-in-cardiac-surgery https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/masywne-krwawienia https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-albumin-vn https://sciencehub.octapharma.com/resources-sea/newsletter/bleeding-management-fibrinogen-concentrate-in-general-surgery-obstetrics-cases https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/optimizing-ivig-therapy-in-cidp-dose-escalation-strategies-and-clinical-outcomes https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/reversal-of-factor-xa-inhibitors-update-on-specific-and-non-specific-reversal https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/laboratornaya-diagnostika-bolezni-villebranda-ot-rutinnyh-testov-do-specificheskih-markerov https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/post-paracentesis-circulatory-dysfunction https://sciencehub.octapharma.com/e-learnings/e-learning-cc-antithrombin https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/hemostaza_rodzacej_rola_fibrynogenu_w_poloznictwie https://sciencehub.octapharma.com/lectures/south-africa/critical-care https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/pathophysiology-diagnostic-challenges-and-treatment-strategies-in-CIDP https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/early-in-hospital-target-controlled-coagulation-management https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/rol-vwdtest-v-praktike-akusher-ginekologa https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/ascites-pathophysiology-and-general-approach-to-management https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/addressing-challenges-in-surgery https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/fizjologiczna_rola_fibrynogenu_w_masywnym_krwotoku https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2023/caso-clinico-experiencia-con-plasma-s-d https://sciencehub.octapharma.com/resources-sea/spcs-sea/pi-albunorm-ph https://sciencehub.octapharma.com/resources-sea/newsletter/reversal-of-anticoagulation-with-coagulation-factor-concentrates https://sciencehub.octapharma.com/e-learnings/e-learning-cc-fibrinogen https://sciencehub.octapharma.com/resources-cis/belarus/events/2026/vedenie-krovotechenij-ot-klinicheskih-algoritmov-k-ekonomicheski-obosnovannoj-terapii https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2026/caso-clinico-hemorragia-en-cirugia-cardiaca https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/the-science-behind-immunomodulation https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/pre-hospital-bleeding-management https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/anomalnye-matochnye-krovotecheniya-kak-marker-zabolevanij-sistemy-gemostaza https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/clinical-case-and-interactive-session-2 https://sciencehub.octapharma.com/resources-spain/hemostasia https://sciencehub.octapharma.com/e-learnings/e-learning-cc-haemostasis https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/is-it-time-to-replace-plasma-with-4f-pcc-in-cardiac-surgery- https://sciencehub.octapharma.com/resources-cis/belarus/events https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/krwotok-polozniczy-rola-fibrynogenu-i-zasady-wsparcia-hemostazy https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2023/caso-clinico-optimizacion-de-las-transfusiones https://sciencehub.octapharma.com/lectures/sea/critical-care/2023/use-of-4f-pcc-in-cardiac-surgery https://sciencehub.octapharma.com/resources-cis/belarus/events/2026/racionalnaya-terapiya-gemofilii-a-ot-farmakoekonomicheskoj-ocenki-k-resheniyu https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2026/caso-clinico-manejo-perioperatorio-y-de-la-hemorragia-en-cirugia-hepatica https://sciencehub.octapharma.com/resources-cis/belarus/publications https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/advances-in-immunomodulatory-and-targeted-treatments-for-autoimmune-diseases https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/coagulation-management-in-liver-disease https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/bolezn-villebranda-problemy-svoevremennoj-diagnostiki https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/hepatic-encephalopathy https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/factor-i-the-first-to-replace- https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/caso-clinico-ii-hemorragias-de-coagulopatia-en-ptes-anticoagulados-y-o-antiagregados https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/caso-clinico-ii-hemorragias-de-coagulopatia-en-ptes-anticoagulados-y-o-antiagregados https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/miejsce-koncentratu-fibrynogenu-w-leczeniu-krwotoku-polozniczego https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2023/caso-clinico-impacto-del-uso-del-fibrinogeno-en-pacientes-con-preeclampsia https://sciencehub.octapharma.com/lectures/sea/critical-care/2023/synergy-of-clotting-factor-concentrates-in-liver-surgery https://sciencehub.octapharma.com/resources-south-africa/product-leaflets/product-leaflets/octaplex-pi-za https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-albunorm-id https://sciencehub.octapharma.com/resources-sea/newsletter/bleeding-management-a-case-for-fibrinogen-concentrate https://sciencehub.octapharma.com/e-learnings/e-learning-cc-pbm https://sciencehub.octapharma.com/resources-cis/belarus/events/2026/bolezn-villebranda-segodnya-ot-klinicheskih-sluchaev-k-effektivnym-resheniyam https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2026/caso-clinico-hemorragia-en-paciente-politraumatizado https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/coagulation-management-in-pph https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/chasto-li-u-menya-sluchayutsya-krovotecheniya-povyshenie-osvedomlennosti-o-bv https://sciencehub.octapharma.com/lectures/sea/critical-care/2025/navigating-massive-hemorrhage-during-right-hepatectomy https://sciencehub.octapharma.com/resources-russia/lectures/bm/2025/bridging-data-and-delivery-integrating-advanced-hemostatic-strategies-in-critical-care https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2025/managing-high-risk-surgical-bleeding-a-hemipelvectomy-case-example https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/clinical-case-and-interactive-session-1 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/bridging-data-and-delivery-integrating-advanced-hemostatic-strategies-in-critical-care https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/caso-clinico-i-terapia-guiada-en-coagulopatias-complejas https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/caso-clinico-i-terapia-guiada-en-coagulopatias-complejas https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/esaic-2025/esaic-2025 https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2024/when-to-reverse-doacs-in-the-perioperative-period https://sciencehub.octapharma.com/resources-russia/lectures/bm/2024/when-to-reverse-doacs-in-the-perioperative-period https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2024/manifestation-variants-of-primary-immunodeficiencies https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/koncentrat-fibrynogenu-y-praktyce-kardioanestezjologa https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2023/caso-clinico-hemorragia-asociada-a-trauma https://sciencehub.octapharma.com/lectures/sea/critical-care/2023/synergy-of-clotting-factor-concentrates-in-cardiac-surgery https://sciencehub.octapharma.com/science-hub-portugal https://sciencehub.octapharma.com/resources-south-africa/product-leaflets/product-leaflets/albumin-pi-za https://sciencehub.octapharma.com/lectures/mena/critical-care/2022/prothrombin-complex-concentrate-pcc-characteristics-and-experience-in-different-clinical-settings https://sciencehub.octapharma.com/events https://sciencehub.octapharma.com/resources-sea https://sciencehub.octapharma.com/e-learnings/e-learning-cc-pcc https://sciencehub.octapharma.com/resources-south-africa https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2020/esid-2020-potential-use-of-immunoglobulin-covid-19 https://sciencehub.octapharma.com/ https://sciencehub.octapharma.com/clinical-trials https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/bm/2026/prakticheskoe-posobie-dekompensirovannyj-cirroz-pecheni https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2026/plasma-exchange-in-sepsis-where-do-we-stand https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2026/controversias-en-el-manejo-multimodal-de-la-hemorragia-grave https://sciencehub.octapharma.com/science-hub-portugal/resumo-das-palestras https://sciencehub.octapharma.com/lectures/portugal/immunotherapy/2026/indicacoes-para-a-terapeutica-de-reposicao-com-ig https://sciencehub.octapharma.com/resources-cis/belarus/publications/im/2025/registr-pervichnyh-immunodeficitov-v-respublike-belarus-20-letnij-opyt https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/dermatomyositis-new-evidence-on-the-therapeutic-role-of-immunoglobulins https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/coagulation-management-in-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2026/isicem-2026/isicem-2026 https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/navigating-immune-challenges-when-targeting-plasma-cells https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/are-b-cell-depleting-therapies-opening-the-door-for-infections- https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/compromised-immunity-the-hidden-challenge- https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/navigating-the-transition-from-paediatric-to-adult-care https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/are-secondary-immunodeficiencies-lost-in-translation-stephen-jolles https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/are-secondary-immunodeficiencies-lost-in-translation-sara-barmettler https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/kogda-lor-patologii-nedostatochno https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/CLL-impact-of-disease-and-treatment https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025 https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2025/superiority-of-factor-concentrates-for-haemostasis-control-in-cardiac-surgery-russian https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2025/esid-eha-siope/esid-eha-siope-2025-octapharma-symposium https://sciencehub.octapharma.com/lectures/sea/critical-care/2025/bleeding-management-in-cardiac-surgery-a-surgeon-perspective https://sciencehub.octapharma.com/resources-russia/lectures/bm/2025/thrombin-generation-second-preliminary-analysis-of-the-fares-ii-trial https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2025/the-role-of-fibrinogen-in-the-treatment-of-acute-hemorrhage-update https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/thrombin-generation-second-preliminary-analysis-of-the-fares-ii-trial https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/mesa-de-debate-nuevos-avances-en-reanlmacl6n-hemostatica https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/mesa-de-debate-nuevos-avances-en-reanlmacl6n-hemostatica https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/early-detection-of-primary-antibody-deficiencies-in-primary-care-with-screening-algorithms https://sciencehub.octapharma.com/resources-russia https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2024/coagulation-management-in-liver-transplantation https://sciencehub.octapharma.com/resources-russia/lectures/bm/2024/coagulation-management-in-liver-transplantation https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/ostra-koagulopatia-pourazowa https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2023/caso-clinico-falla-hepatica-aguda-y-tce https://sciencehub.octapharma.com/lectures/sea/critical-care/2023/perioperative-bleeding-management-without-vha https://sciencehub.octapharma.com/resources-sea/sea-lectures-overview https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-octaplex-id https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/bm/2026/klinicheskij-protokol-mz-rb-diagnostika-i-lechenie-pacientov-vzrosloe-naselenie-s-zabolevaniyami-pecheni https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2026/uncovering-the-potential-impact-of-plasma-in-coagulation https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/im/2026/klinicheskie-rekomendacii-mz-rf-agressivnye-nefollikulyarnye-limfomy- https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2026/thromboelastic-assays-different-targets-in-different-scenarios https://sciencehub.octapharma.com/lectures/portugal/immunotherapy/2026/ig-humana-em-situacoes-criticas https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2026/povyshaet-li-risk-infekcij-terapiya-podavlyayushayaya-v-kletki- https://sciencehub.octapharma.com/resources-cis/belarus/publications/im/2025/znachenie-pulmonologii-v-vyyavlenii-i-lechenii-pacientov-s-pid https://sciencehub.octapharma.com/resources-cis/belarus/events/2026/korrekciya-gemostaza-pri-onkogematologicheskih-zabolevaniyah https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/goal-directed-bleeding-management https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2025/vid-i-car-t-terapiya_profilaktika-oslozhnenij https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/von-willebrand-disease https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2025/pharmacoeconomic-analysis-of-fibrinogen-concentrate-in-hypofibrinogenemia-in-belarus https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2025/ipic/octapharma-symposium https://sciencehub.octapharma.com/lectures/sea/critical-care/2025/advancements-in-bleeding-management-in-cardiac-surgery https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2025/obstetric-hemorrhage-interdisciplinary-challenge-uterine-rupture https://sciencehub.octapharma.com/resources-russia/lectures/bm/2025/superiority-of-factor-concentrates-for-haemostasis-control-in-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/hyponatremia https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/fibrinogen-first-redefining-hemostasis-in-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2025/eha/update-in-hematology https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24 https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/artificial-intelligence-to-shorten-diagnosis-of-patients-with-primary-immunodeficiencies-and-detect-phenotypic-patterns-of-rare-diseases https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2024/facing-bleeding-challenges-in-cardiac-surgery https://sciencehub.octapharma.com/resources-russia/lectures/bm/2024/facing-bleeding-challenges-in-cardiac-surgery https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2024/rhesus-factor-negative-what-to-do-about-it https://sciencehub.octapharma.com/resources-mexico https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/krwotok-pourazowy-rola-fibrynogenu https://sciencehub.octapharma.com/resources-brazil https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2023/caso-clinico-hemorragia-en-la-uci https://sciencehub.octapharma.com/lectures/sea/critical-care/2023/haemorrhagic-shock-coagulopathy-in-polytrauma https://sciencehub.octapharma.com/resources-spain/almas https://sciencehub.octapharma.com/resources-latam https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2022/optimising-pre-hospital-trauma-resuscitation https://sciencehub.octapharma.com/resources-tksaarc https://sciencehub.octapharma.com/lectures/mena/critical-care/2022/the-use-of-coagulation-factor-concentrates-for-bleeding-management https://sciencehub.octapharma.com/events/headquarters/critical-care/2026/isth-2026/isth-2026 https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/bm/2026/klinicheskie-rekomendacii-mz-rf-gemorragicheskij-insult https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2026/smarter-decision-making-plasma-vs-factor-concentrates https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/im/2026/klinicheskie-rekomendacii-mz-rf-follikulyarnaya-limfoma https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2026/debate-pro-con-sobre-el-uso-actual-del-fibrinogeno https://sciencehub.octapharma.com/lectures/portugal/immunotherapy/2026/criterios-para-selecao-da-via-iv-vs-sc https://sciencehub.octapharma.com/events/headquarters/critical-care/2026/nata-2026/nata-2026 https://sciencehub.octapharma.com/events/headquarters/critical-care/2026/esaic-2026/esaic-2026 https://sciencehub.octapharma.com/resources-cis/belarus/publications/hm/2026/profilaktika-3-tipa-bv-dannye-issledovaniya-will-31 https://sciencehub.octapharma.com/resources-mexico/inmunologia-en-la-practica-clinica https://sciencehub.octapharma.com/resources-cis/belarus/events/2026/innovacii-i-praktika-v-pediatrii https://sciencehub.octapharma.com/events/headquarters/critical-care/2026/lcmm-2026 https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2026/yarosh_successful-pid-treatment-with-scig https://sciencehub.octapharma.com/events/latam/immunotherapy/2026 https://sciencehub.octapharma.com/resources-cis/belarus/events/2025/issledovanie-gan-12-vozmozhnosti-zamestitelnoj-terapii-vtorichnyh-immunodeficitov-v-onkogematologii-i-onkologii https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/presentations-25/how-to-implement-pbm-into-our-daily-practice https://sciencehub.octapharma.com/resources-cis/belarus/recommendations https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/managing-secondary-antibody-deficiency-in-clinical-practice https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/asa-2025/asa-2025 https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2025/controversies-in-immunological-assessment https://sciencehub.octapharma.com/events/sea/critical-care/2025/asca-2025/innovators-in-bleeding-management https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2025/heart-transplant-what-could-go-wrong- https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/renal-failure-in-cirrhosis https://sciencehub.octapharma.com/resources-russia/lectures/bm/2025/rebalancing-haemostasis-in-factor-xa-inh-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/limitations-of-blood-transfusions-and-the-promise-of-concentrate-based-therapy https://sciencehub.octapharma.com/science-hub-usa/2025/sca-2025/sca-2025 https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/actualizacion-bibliografico-en-fibrinogeno https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/nata-2025/nata-2025/nata-2025 https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/actualizacion-bibliografico-en-fibrinogeno https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/isth-2025/isth-2025 https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/sca-2025/sca-2025 https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/isicem-2025/isicem-2025 https://sciencehub.octapharma.com/science-hub-usa/2024/asa-24/revolutionizing-bleeding-management-US https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/why-do-we-need-artificial-intelligence https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024 https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2022/specific-and-non-specific-strategies-in-DOAC-reversal https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2023/management-of-patients-on-fXa-inhibitors-in-emergencies https://sciencehub.octapharma.com/resources-russia/lectures/bm/2023/management-of-patients-on-fXa-inhibitors-in-emergencies https://sciencehub.octapharma.com/resources-russia/lectures/bm/2022/specific-and-non-specific-strategies-in-DOAC-reversal https://sciencehub.octapharma.com/resources-russia/lectures/bm/2024/bleeding-management-in-liver-transplantation-can-we-strike-a-balance https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2024/willebrand-s-disease https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2024/secondary-immunodeficiencies-sids-in-oncohematology https://sciencehub.octapharma.com/guidelines/bleeding-management/guidelines-on-bleeding-management https://sciencehub.octapharma.com/lectures/cee/critical-care/poland/2024/koncentrat-fibrynogenu-i-octaplaslg-w-kardiochirugii-i-transplantologii https://sciencehub.octapharma.com/events/latam/critical-care/2024/2024 https://sciencehub.octapharma.com/resources-cis/belarus/publications/hm/2025/pharmacoeconomic-analysis-of-the-use-of-IIT-therapy https://sciencehub.octapharma.com/resources-cis/belarus/publications/bm/2025/reduced-mortality-with-albumin-use-in-patients-with-ards https://sciencehub.octapharma.com/resources-cis/belarus/publications/im/2025/pharmacoeconomic-evaluation-of-the-use-of-Scuvig-in-patients-with-pid https://sciencehub.octapharma.com/science-hub-italy/autoimmune-diseases/dermatomyositis/sir-2023/terapia-con-ig-endovena-nelle-miopatie-idiopatiche-infiammatorie-iim-dai-trials-clinici-alla-real-life https://sciencehub.octapharma.com/events/usa/critical-care/2023/cross-specialty-advisory-board https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2023/caso-clinico-hemorragia-durante-cirugia-cardiaca https://sciencehub.octapharma.com/lectures/headquarters/critical-care/review-video/review-video https://sciencehub.octapharma.com/lectures/tksaarc/critical-care/2023/pbm-and-concentrates-in-ich-and-tic https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/role-of-4f-pcc-and-fibrinogen-concentrate-in-managing-bleeding-patients https://sciencehub.octapharma.com/lectures/sea/critical-care/2023/synergy-of-clotting-factor-concentrates-in-emergency-settings https://sciencehub.octapharma.com/science-hub-italy/bleeding-management/bm_articles/2022/octaplaslg/octaplaslg-vs-octaplaslg-lyo-vs-ffp https://sciencehub.octapharma.com/lectures/south-africa/critical-care/2022/diagnosis-and-treatment-of-pph https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/por-que-sangran-los-pacientes https://sciencehub.octapharma.com/resources-canada/autoimmune-diseases https://sciencehub.octapharma.com/resources-canada/immunodeficiencies https://sciencehub.octapharma.com/resources-canada/optimal-utilization-of-blood-products https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2022/early-identification-of-tic https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-fibryga-sg https://sciencehub.octapharma.com/resources-sea/newsletter/nl1-reversal-of-doacs-with-4f-pcc https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2021/eular-2021-proderm-results-isni https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2021/eular-2021-proderm-results https://sciencehub.octapharma.com/lectures/mena/critical-care/2022/sd-plasma-characteristics-and-experience-in-different-clinical-settings https://sciencehub.octapharma.com/lectures/tksaarc/critical-care/lectures-tk-saarc/role-of-4f-pcc-in-bleeding-management https://sciencehub.octapharma.com/octapharma https://sciencehub.octapharma.com/lectures/portugal/immunotherapy/2026/gestao-e-prevencao-de-complicacoes-da-ig-humana https://sciencehub.octapharma.com/e-learnings/e-learning-cc-cardiac-surgical-bleeding https://sciencehub.octapharma.com/podcast/headquarters/immunotherapy/2025/sid-patients-with-an-underlying-pid https://sciencehub.octapharma.com/resources-cis/belarus/publications/im/2025/sid-following-car-t-therapy https://sciencehub.octapharma.com/events/latam/immunotherapy/2026/programme https://sciencehub.octapharma.com/resources-cis/belarus/events/2025/slozhnye-sluchai-bolezni-villebranda-opyt-i-resheniya https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/treating-antibody-deficiency-in-patients-with-haematologic-malignancies https://sciencehub.octapharma.com/resources-cis/belarus/lectures/ha-vwd/2025/factor-therapy-for-hemophilia-a-in-the-era-of-emicizumab https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2025/rebalancing-haemostasis-in-factor-xa-inh-patients-russian https://sciencehub.octapharma.com/resources-cis/belarus/publications/bm/2025/combined-deficiencies-of-clotting-factors https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/the-albumin-molecule-in-patients-with-cirrhosis https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/mesa-de-ccp https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/mesa-de-ccp https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/all-you-want-to-know-about-plasma-exchange-in-septic-shock https://sciencehub.octapharma.com/science-hub-usa/2024/asa-24/revolutionizing-bleeding-management https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/innovative-approaches-in-cardiac-surgery https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/sid-in-paediatric-hematologic-malignancies https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/sid-in-multiple-myeloma-mm https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/organization-of-care https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/sid-in-cll https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/sid-in-non-hodgkins-lymphoma https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/substitution-therapy-with-immunoglobulin-products https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/autoimmunity-and-immunodeficiency https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/pids-and-sids-overlaps https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/secondary-immune-deficiencies-overview https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/pid-with-antibody-deficiencies https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/immunity-and-its-impairment https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos https://sciencehub.octapharma.com/resources-russia/lectures https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2024/bleeding-management-in-liver-transplantation-can-we-strike-a-balance https://sciencehub.octapharma.com/resources-russia/lectures/bm/2021/haemostasis-management-during-liver-transplantation https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2024/esid/octapharma-symposium https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2023/the-use-of-ivig-in-the-treatment-of-cvdp https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2023/modern-approaches-to-the-treatment-of-severe-blood-loss https://sciencehub.octapharma.com/resources-russia/lectures/im/2024/use-of-subcutaneous-immunoglobulin-in-the-treatment-of-patients-with-vdi-results-of-an-observational-study https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2022/microcirculation-and-coagulation-in-critical-conditions https://sciencehub.octapharma.com/resources-cis/belarus/lectures https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/im/2025/scig-instruction https://sciencehub.octapharma.com/resources-cee https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/guias-clinicas-para-ia-hemorragia-posparto https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/manejo-de-hemorragias-y-trombosis-en-ecmo https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/abordaje-de-ia-hemorragia-critica-en-ia-uci https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/manejo-hemostatico-de-pts-pediatricos-sometidos-a-cirugia-mayor-de-columna https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/estrategias-transfusionales-en-hemorragia-masiva https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/lmportancia-de-ia-generacion-de-trombina-en-ia-cirugia-cardiaca https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/tratamiento-de-ia-coagulopatia-en-pacientes-politraumatizados https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/control-de-ia-hemorragia-masiva-dirigida-por-objetivos https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/tratamiento-de-ia-hemorragia-asociada-a-ia-anticoagulacion-oral https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/estudios-viscoelasticos-vs-test-clasicos-en-pts-sangrantes https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/resultados-del-pbm-en-el-trasplante-hepatico https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/impacto-del-pbm-en-el-paciente-quirurgico https://sciencehub.octapharma.com/lectures/latam/critical-care/2024/bases_para_Ia_implementacion_de_pbm https://sciencehub.octapharma.com/events/latam/critical-care/2024/programme-2024 https://sciencehub.octapharma.com/resources-cis/belarus/publications/hm/2025/development-of-a-method-of-primary-screening-of-willebrands-disease https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/esaic-2024/esaic-2024 https://sciencehub.octapharma.com/resources-cis https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/isicem-2024/isicem-2024 https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/wca-2024 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/hemorragia-obstetrica-y-coagulacion https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/algoritmo-de-manejo-de-coagulopatia-en-el-paciente-critico-cardiovascular https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2023/ipic-congress/symposium https://sciencehub.octapharma.com/resources-russia/lectures/im/2023/3 https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/esaic-2023/esaic-2023 https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/isicem-2023/2023 https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/principles-of-coagulation-management-in-massive-bleeding https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/goal-directed-approach-to-bleeding-management https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/conventional-coagulation-approach-to-bleeding-management https://sciencehub.octapharma.com/resources-canada/bleed-management https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2022/separacion-de-siamesas https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/importancia-de-pruebas-viscoelasticas-para-el-tratamiento-individualizado-en-cirugia-cardiovascular https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022 https://sciencehub.octapharma.com/lectures/italy/critical-care/2022/nuove-prospettive-nella-gestione-dell-emorragia-critica-quale-ruolo-del-fibrinogeno https://sciencehub.octapharma.com/resources-south-africa/product-leaflets/animated-brochures/animated-octaplex-leaflet https://sciencehub.octapharma.com/lectures/south-africa/critical-care/2022/management-of-anticoagulated-patients-on-oacs https://sciencehub.octapharma.com/resources-south-africa/round-table-meeting https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2021/eha-congress https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/esaic-2022 https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/isicem-2022 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/effect-of-covid-19-on-transfusion-availability https://sciencehub.octapharma.com/resources-mena https://sciencehub.octapharma.com/lectures/sea/critical-care/2021/reversal-of-anticoagulation-with-coagulation-factor-concentrates https://sciencehub.octapharma.com/octapharma/legal-statement https://sciencehub.octapharma.com/lectures/portugal/immunotherapy/2026/utilizacao-de-igsc-em-patologias-imunomediadas-cronicas https://sciencehub.octapharma.com/podcast/headquarters/immunotherapy/2025/sid-paediatric-cancer-infections-as-warning https://sciencehub.octapharma.com/events/latam/immunotherapy/2026/faculty https://sciencehub.octapharma.com/events/headquarters/critical-care/2026/isicem-2026/booth/scientific-publications https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/optimizing-perioperative-transfusion-a-surgeons-perspective https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2025/multiple-myeloma-how-to-mitigate-the-risk-of-infection https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/patophysiology-of-decompensated-cirrhosis https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/seguridad-del-concentrado-de-complejo-de-protrombina https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/seguridad-del-concentrado-de-complejo-de-protrombina https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/navigating-the-unexpected-tackling-challenging-bleeding-in-the-or https://sciencehub.octapharma.com/science-hub-usa/2024/asa-24/advancing-fibrinogen-deficiency-management https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/isicem-2025/isicem-2025-octapharma-booth https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/advances-in-bleeding-management-for-pph https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/eha-2024-interactive-panel-discussion-challenging-cases-involving-infections-associated-with-multiple-myeloma https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/eha-2024-clinical-data-on-the-use-of-intravenous-or-subcutaneous-immunoglobulins-mouthon https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/eha-2024-reducing-infections-recommendations-guidelines-and-perspectives-ria https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/eha-2024-bispecific-antibodies-and-car-t-cells-handling-the-infection-risk-related-to-their-use https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2024/identifying-the-risk-of-infections-in-multiple-myeloma-impact-of-disease-treatment-and-supportive-care https://sciencehub.octapharma.com/resources-russia/lectures/bm/2021/pragmatic-management-of-bleeding-during-cardiac-surgery https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2024/finding-the-balance-between-bleeding-and-thrombosis https://sciencehub.octapharma.com/resources-cis/belarus/lectures/im/2023/secondary-immunodeficiencies-in-lymphoproliferative-diseases https://sciencehub.octapharma.com/resources-russia/lectures/im/2024/subcutaneous-immunoglobulins-in-adults-useful-tips-in-providing-and-administering-therapy https://sciencehub.octapharma.com/resources-brazil/resumo-das-apresentadas https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/finding-the-balance-between-bleeding-and-thrombosis https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/coagulation-management-in-liver-transplantation https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/when-to-reverse-doacs-in-the-perioperative-period https://sciencehub.octapharma.com/resources-mexico/resumen-de-ponencias-Mexico https://sciencehub.octapharma.com/resources-cee/resources-cee https://sciencehub.octapharma.com/events/latam/critical-care/2024/speaker-panel-2024 https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/isicem-2024/isicem-2024-octapharma-booth https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/thrombosis-prophylaxis-in-critically-ill-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/wca-2024/wca-2024-octapharma-booth https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2023/focusgroup/aconversationaboutdermatomyositis https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023 https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/papel-del-fibrinogeno-en-hemorragia-masiva https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/novedades-en-cit https://sciencehub.octapharma.com/resources-russia/lectures/im/2023/2 https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2023/pns-congress-2023 https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2023/eha-congress/Update-in-Hematology https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/isicem-2023/isicem-2023-octapharma-booth https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/case-discussion-iii-icu https://sciencehub.octapharma.com/resources-canada/bleed-management/ca-warfarin-and-doac-reversal https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2022/coagulopatia-asociada-a-trauma-en-el-paciente-critico https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/experiencia-clinica-con-plasma-s-d https://sciencehub.octapharma.com/resources-latam/resumen-de-ponencias-latam https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/msg-meeting-2022 https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/esid-congress-2022 https://sciencehub.octapharma.com/resources-south-africa/product-leaflets https://sciencehub.octapharma.com/resources-south-africa/product-information/product-information https://sciencehub.octapharma.com/resources-mena/mena-lectures-overview https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/gcom-congress-2022-symposium-slides-downloads https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/gcom-conference https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-albunorm-sg https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/ipic-congress-2022 https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/eha-congress-2022 https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/pns-congress-2022 https://sciencehub.octapharma.com/resources-south-africa/round-table-meeting/round-table-meeting-on-massive-haemorrhage https://sciencehub.octapharma.com/lectures/south-africa/critical-care/2022/warfarin-toxicity-and-pcc-a-state-sector-perspective https://sciencehub.octapharma.com/clinical-trials/immunotherapy/procid-trial-pns-2022 https://sciencehub.octapharma.com/resources-tksaarc/resources-india/octaplex-spc-in https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2022/pns-congress https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2022/targeting-microcirculation-and-coagulation-in-critical-illness https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/isicem-2022/isicem-2022-octapharma-booth https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/alternatives-to-transfusion-the-pbm-approach https://sciencehub.octapharma.com/clinical-trials/immunotherapy/proderm-trial https://sciencehub.octapharma.com/clinical-trials/immunotherapy/procid-trial https://sciencehub.octapharma.com/clinical-trials/immunotherapy/procid-trial-isni https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2021/esid-2021 https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2021/eha-2021 https://sciencehub.octapharma.com/octapharma/pharmacovigilance-data-privacy-statement https://sciencehub.octapharma.com/_common/sciencehub-welcome https://sciencehub.octapharma.com/octapharma/privacy-statement https://sciencehub.octapharma.com/profile/support https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2026/aan/itu https://sciencehub.octapharma.com/podcast/headquarters/immunotherapy/2025/sid-the-hidden-diagnosis https://sciencehub.octapharma.com/events/latam/immunotherapy/2026/logistics https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/logistics https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/lectures/natural-history-of-cirrhosis https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/reversion-de-acods https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/reversion-de-acods https://sciencehub.octapharma.com/clinical-trials/critical-care/fares-ii-trial https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/isicem-2025/scientific-publications https://sciencehub.octapharma.com/science-hub-usa/2024/asa-24/pospartum-hemorrhage-and-the-role-of-fibrinogen-concentrate https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/challenges-and-solutions-to-treat-coagulation-disorders-in-liver-failure https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/logistics https://sciencehub.octapharma.com/resources-cis/belarus/lectures/bm/2024/targeted-therapies-for-tic-novel-haemostatic-approached https://sciencehub.octapharma.com/resources-cee/bm-workshop-24 https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2024/eha/Update-in-Hematology https://sciencehub.octapharma.com/events/latam/critical-care/2024/logistics-2024 https://sciencehub.octapharma.com/resources-cis/belarus/publications/hm/2025/induction-of-immune-tolerance https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/esaic-2024/scientific-publications https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/im/2025/diagnosis-of-primary-immunodeficiencies https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/isicem-2024/scientific-publications https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/liver-failure-and-hemostasis https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/wca-2024/scientific-publications https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/logistics https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/concentrado-de-protrombina-en-la-hemorragia-quirurgica https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/obstetric-haemorrhage-and-coagulation https://sciencehub.octapharma.com/resources-russia/lectures/im/2023/1 https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/isicem-2023/scientific-publications https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/paediatric-bleeding-management https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/4F-pcc-in-cardiac-surgery https://sciencehub.octapharma.com/resources-canada/bleed-management/ca-traumatic-bleed-management https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2022/hemorragia-postparto https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/estrategias-de-transfusion-en-hemorragia-masiva https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-octaplex-sg https://sciencehub.octapharma.com/lectures/south-africa/critical-care/2022/massive-haemorrhage-in-anticoagulated-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/esaic-2022/esaic-2022-octapharma-booth-2 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2022/therapeutic-approach-of-trauma-induced-coagulopathy-remaining-gaps https://sciencehub.octapharma.com/resources-south-africa/round-table-meeting/round-table-on-life-threatening-haemorrhage-in-anticoagulated-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/isicem-2022/scientific-publications https://sciencehub.octapharma.com/resources-russia/lectures/bm/2021/svojstva-chelovecheskogo-albumina-i-rezultaty-issledovaniya-answer https://sciencehub.octapharma.com/lectures/brazil/critical-care/2024/controle-da-hemorragia-no-transplante-de-figado-sera-possivel-encontrar-um-equilibrio https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/speakers https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/speakers https://sciencehub.octapharma.com/resources-latam/jornada-del-sangrado-es/reversion-de-antagonistas-de-la-vitamina-k https://sciencehub.octapharma.com/resources-spain/jornada-multidisciplinar/2025/reversion-de-antagonistas-de-la-vitamina-k https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/superiority-of-factor-concentrates-for-haemostasis-control-in-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/isicem-2025/promotional-materials https://sciencehub.octapharma.com/science-hub-usa/2024/asa-24/early-goal-directed-fibrinogen-therapy-in-trauma https://sciencehub.octapharma.com/clinical-trials/critical-care/proxy-trial https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/case-discussion-i https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/speakers https://sciencehub.octapharma.com/resources-latam/almas https://sciencehub.octapharma.com/resources-mexico/casos-clinicos-mexico https://sciencehub.octapharma.com/events/latam/critical-care/2024/documents-2024 https://sciencehub.octapharma.com/resources-cis/belarus/recommendations/im/2025/treatment-of-vid-in-patients-with-cll-and-mm https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/isicem-2024/promotional-materials https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/coagulation-and-inflammation https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/wca-2024/promotional-materials https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/speakers https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/manejo-del-sangrado-en-pacientes-tratados-con-anticoagulantes-orales https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/glass-half-full-or-half-empty-management-of-post-traumatic-bleeding https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/isicem-2023/promotional-materials https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/management-of-traumatic-brain-injury https://sciencehub.octapharma.com/resources-canada/bleed-management/ca-coagulation-dysfunction-in-surgery-trauma-and-critical-illness https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/patient-blood-management-in-children https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2022/validacion-del-fibrinogeno-como-predictor-de-severidad-en-hpp https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/speakers https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/esaic-2022/promotional-material-esaic-22 https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-albunorm-my https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2022/specific-and-non-specific-strategies-in-doac-reversal https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/isicem-2022/promotional-materials https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/coagulation-monitoring https://sciencehub.octapharma.com/lectures/headquarters/immunotherapy/2020/eha25virtual-congress https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2026/ean/satellite-symposium https://sciencehub.octapharma.com/lectures/brazil/critical-care/2024/enfrentar-os-desafios-da-hemorragia-na-cirurgia-cardiaca https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/bmm-2025/programme https://sciencehub.octapharma.com/events/headquarters/critical-care/2025/lcmm/programme https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2025/ean/satellite-symposium https://sciencehub.octapharma.com/science-hub-usa/2024/asa-24/precision-and-innovation-in-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/how-to-implement-pbm-in-our-daily-practice https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/programme https://sciencehub.octapharma.com/clinical-trials/critical-care/lex-209-trial https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/case-discussion-iii https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/programme https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/manejo-de-la-coagulopatia-inducida-por-el-trauma https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/management-of-major-haemorrhage-after-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/management-of-bleeding-in-trauma-update-of-eu-guidelines https://sciencehub.octapharma.com/resources-canada/bleed-management/ca-surgical-bleed-management https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/Save-cost-effective-management-of-bleeding-in-cardiac-surgery https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2022/cirugia-cardiovascular-pediatrica https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/guias-y-protocolos-del-manejo-del-sangrado-espana-latam https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/programme https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/esaic-2022/scientific-publications-esaic-22 https://sciencehub.octapharma.com/resources-sea/spcs-sea/spc-octaplex-my https://sciencehub.octapharma.com/profile/password-change https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/rotem-in-covid-19-associated-coagulopathy https://sciencehub.octapharma.com/lectures/brazil/critical-care/2024/para-alem-da-hemorragia https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2025/rebalancing-haemostasis-in-factor-xa-inh-patients https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2025/aan/itu https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/perioperative-bleeding-guidelines https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2024/aan https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/bleeding-management-in-neurosurgery https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/pbm-en-cirugia-mayor-y-trasplante-hepatico-en-pediatria https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/management-of-patients-on-fxa-inhibitors-in-emergencies https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/prehospital-bleeding-management https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2022/hemorragia-masiva https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/6b7d1da4-32a7-45b6-a76f-98c6273069ba https://sciencehub.octapharma.com/lectures/sea/critical-care/2022/reversal-of-doacs-with-4f-pcc https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/pbm-in-trauma-patients https://sciencehub.octapharma.com/clinical-trials/critical-care/fares-trial https://sciencehub.octapharma.com/events/headquarters/critical-care/2026/isicem-2026/booth/promotional-materials https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/case-discussion-ii https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/bleeding-management-in-liver-transplantation-can-we-strike-a-balance https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2024/gcom https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/postpartum-hemorrhage https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/manejo-de-la-hemostasis-en-el-trasplante-hepatico https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/what-is-new-in-tic https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/coagulation-lab-tests-vs-viscoelastic-testing https://sciencehub.octapharma.com/resources-latam/latam-casos-clinicos/2022/codigo-rojo-traumatico https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/manejo-de-la-hemorragia-en-pacientes-con-trauma https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/pbm-in-paediatric-patients https://sciencehub.octapharma.com/clinical-trials/critical-care/fibres-trial https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/pre-hospital-bleeding-management https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2024/pns-congress-2024 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/facing-bleeding-challenges-in-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/reversal-of-anticoagulant-drugs https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/manejo-avanzado-de-la-hemorragia-severa-posparto https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/prehospital-bleeding-management https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/case-discussion-i https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/uso-del-concentrado-de-fibrinogeno-en-el-manejo-de-sangrado https://sciencehub.octapharma.com/profile/questions-and-suggestions https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/management-of-coagulopathy-during-paediatric-cardiac-surgery https://sciencehub.octapharma.com/clinical-trials/critical-care/forma-05-trial https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2025/chicago/innovation-theater https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/early-in-hospital-target-controlled-coagulation-management https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/beyond-bleeding-precision-medicine-for-personalized-patient-care https://sciencehub.octapharma.com/profile/registration-belarus https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/case-discussion-ii https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/manejo-de-la-hemorragia-en-cirugia-cardiaca https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/tic-a-scattershot-vs-individualised-goal-direct-approach https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/vka-doacs-and-antiplatelet-drugs https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/uso-del-ccp-en-cirugia-cardiaca-perioperatoria https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/key-aspects-in-pph https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/update-on-specific-and-non-specific-reversal-of-fxa-inh https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2024/washington-2024 https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/decoding-coagulopathy-mechanisms https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/coagulation-and-transfusion-in-pediatric-surgery https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/terapias-guiadas-por-objetivos-en-la-reanimacion-hemostatica https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2023/time-to-reconsider-icu-standards https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/coagulation-management-in-the-critically-ill-patient https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/manejo-de-pacientes-anticoagulados-con-antagonistas-de-la-vitamina-k-y-acods https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/haemostatic-management-in-icu-patients https://sciencehub.octapharma.com/events/headquarters/immunotherapy/2026/gcom/octapharma-symposium https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/case-discussion-iii-a https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/targeted-therapies-for-tic-novel-haemostatic-approached https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/bleeding-and-thrombosis-in-ecmo https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/evaluacion-preoperatoria-del-riesgo-hemorragico https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/coagulation-inflammation https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/el-valor-de-los-protocolos-en-el-manejo-de-la-hemorragia https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/haemostasis-management-during-liver-transplantation https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/case-discussion-iiib https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2024/singapore-case-study-using-factor-concentrates https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/coagulation-management-in-cardiac-surgery https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/implementacion-de-pbm-experiencia-de-la-sociedad-iberoamericana https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/coagulation-factor-concentrates https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/infllammation-and-coagulation https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/case-discussion-i https://sciencehub.octapharma.com/lectures/latam/critical-care/2023/trastornos-hemorragicos-pasado-y-presente https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/update-of-esaic-guideline https://sciencehub.octapharma.com/lectures/latam/critical-care/2022/puntos-criticos-durante-el-tratamiento-inicial-del-shock-hemorragico https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/ecmo-between-bleeding-and-thrombosis https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/target-controlled-coagulation-management-in-trauma https://sciencehub.octapharma.com/events/headquarters/critical-care/2022/bmm-2022/presentations/introduction-to-patient-bleeding-management https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/fundamentals-of-coagulation-management-during-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/anticoagulation-and-thrombosis-prophylaxis-in-critically-ill-patients https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/updated-trauma-guidelines https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/pragmatic-management-of-bleeding-during-cardiac-surgery https://sciencehub.octapharma.com/events/headquarters/critical-care/2024/bmm-2024/presentations-24/case-discussion-iv https://sciencehub.octapharma.com/events/headquarters/critical-care/2023/bmm-2023/presentations/patient-blood-management https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/clinical-relevance-of-thrombin-generation-when-do-we-need-a-prothrombin-boost https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/haemostatic-management-in-covid-patients https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/effects-of-different-fluids-in-shock-on-endothelial-permeability https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/management-of-doac-associated-bleeding https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/evidence-based-use-of-albumin-in-liver-cirrhosis https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/role-of-long-term-albumin-administration-in-cirrhosis-ascites-the-answer-trial https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/early-management-of-tic https://sciencehub.octapharma.com/lectures/headquarters/critical-care/2021/the-pbm-approach-in-bleeding-management